HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis

Virology

Volumn 224, Issue 1, 1996, Pages 292-301

  Wiskerchen, Maryann ^a   Cheng Mayer, Cecilia ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; PROTEIN SERINE KINASE;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030273317     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0531     Document Type: Article

References (60)

1. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., and Trono, D. (1994). Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864.
2. Aiken, C., and Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048-5056.
3. Allan, J. S., Coligan, J. E., Lee, T. H., McLane, M. F., Kanki, P. J., Groopman, J. E., and Essex, M. (1985). Anew HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810-813.
4. Anderson, S., Shugars, D. C., Swanstrom, R., and Garcia, J. V. (1993). Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 67, 4923-4931.
5. Backer, J. M., Mendola, C. E., Fairhurst, J. L., and Kovesdi, I. (1991). The HIV-1 nef protein does not have guanine nucleotide binding, GTPase, or autophosphorylating activities. AIDS Res. Human Retroviruses 7: 1015-1020.
6. Bass, S. H., Mulkerrin, M. G., and Wells, J. A. (1991). A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl. Acad. Sci. USA 88, 4498-4502.
7. Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C., and Peterlin, B. M. (1994). HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384.
8. Bukrinskaya, A. G., Ghorpade, A., Henzinger, N. K., Smithgall, T. E., Lewis, R. E., and Stevenson, M. (1996). Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93, 367-371.
9. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J. S., Richman, D. D., and Guatelli, J. C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914.
10. Chowers, M. Y., Pandori, M. W., Spina, C. A., Richman, D. D., and Guatelli, J. C. (1995). The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212, 451-457.
11. Cullen, B. R. (1994). The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205, 1-6.
12. Cunningham, B. C., and Wells, J. A. (1989). High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244, 1081-1085.
13. de Rhonde, A., Klaver, B., Keulen, W., Smit, L., and Goudsmit, J. (1992). Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes. Virology 188, 391-395.
14. De, S. K., and Marsh, J. W. (1994). HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J. Biol. Chem. 269, 6656-6660.
15. Du, Z., Lang, S. M., Sasseville, V. G., Lackner, A. A., Ilyinskii, P. O., Daniel, M. D., Jung, J. U., and Desrosiers, R. C. (1995). Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674.
16. Du, Z., Ilyinskii, P. O., Sasseville, V. G., Newstein, M., Lackner, A. A., and Desrosiers, R. C. (1996). Requirements for lymphocyte activation by unusual strains of simian immunodeficiency virus. J. Virol. 70, 4157-4161.
17. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., and Wong-Staal, F. (1986). HTLV III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46, 807-817.
18. open. Virology 201, 373-379.
19. Franchini, G., Robert-Guroff, M., Ghrayeb, J., Chang, N. T., and Wong-Staal, F. (1986). Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virology 155, 593-599.
20. Garcia, J. V., and Miller, A. D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef. Nature (London) 350, 508.
21. Goldsmith, M. A., Warmerdam, M. T., Atcheson, R. E., Miller, M. D., and Greene, W. C. (1995). Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69, 4112-4121.
22. Greenway, A., Azad, A., and McPhee, D. (1995). Human Immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842-1850.
23. Greenway, A. L., McPhee, D. A., Grgacic, E., Hewish, D., Lucantoni, A., Macreadie, I., and Azad, A. (1994). Nef 27, but not the Nef 25 isoform of human immunodeficiency virus type-1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 198, 245-256.
24. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., Montagnier, L., and Lecocq, J. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (London) 330, 266-269.
25. Guy, B., Riviere, Y., Dott, K., Regnault, A., and Kieny, M. P. (1990). Mutational analysis of the HIV nef protein. Virology 176, 413-425.
26. Harris, M., Hislop, S., Patsilinacos, P., and Neil, J. C. (1992). In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity. AIDS Research and Human Retroviruses 8, 537-543.
27. Harris, M., and Coates, K. (1993). Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation. J. Gen. Virology 14, 1581-1589.
28. Hunter, T. (1995). Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
29. Johnson, G. L., and Vallincourt, R. R. (1994). Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell. Biol. 6, 230-238.
30. Kaminchik, J., Bashan, N., Itach, A., Sarver, N., Gorecki, M., and Panet, A. (1991). Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J. Virol. 65, 583-588.
31. Kestler, H. W., III, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., and Derosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
32. Kim, S. Y., Ikeuchi, K., Byrn, R., Groopman, J., and Baltimore, D. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 9544-9548.
33. Kimpton, J., and Emerman, M. (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66, 2232-2237.
34. Lee, C., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., and Saksela, K. (1995). A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14, 5006-5015.
35. Lee, T. H., Sunzeri, F. J., Tobler, L. H., Williams, B. G., and Busch, M. P. (1991). Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-alpha genes. AIDS 5, 683-691.
36. Lenburg, M. G., and Landau, N. R. (1993). Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67, 7238-7245.
37. Luciw, P. A., Potter, S. J., Steimer, K., Dina, D., and Levy, J. A. (1984). Molecular cloning of AIDS-associated retrovirus. Nature (London) 312, 760-763.
38. Mariani, R., and Skowronski, J. (1993). CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc. Natl. Acad. Sci. USA 90, 5549-5553.
39. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., and Feinberg, M. B. (1994). The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
40. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B., and Greene, W. C. (1995). Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during IV-1 production increases progeny particle infectivity independent of gp160 or viral entry. J. Virol. 69, 579-584.
41. Myers, G., Korber, B., Wain-Hobson, S., Jeang, K. T., Henderson, L. E., and Pavlakis, G. N. (1994). Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, NM.
42. Nebreda, A. R., Bryan, T., Segade, F., Wingfield, P., Venkatesan, S., and Santos, E. (1991). Biochemical and biological comparison of HIV-1 NEF and ras gene products. Virology 183, 151-159.
43. Pandori, M. W., Fitch, N. J. S., Craig, H. M., Richman, D. D., Spina, C. A., and Guatelli, J. C. (1996). Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70, 4283-4290.
44. Ratner, L., and Niederman, T. M. J. (1995). Nef. Curr. Topic Microbiol. Immunol. 193, 169-208.
45. Rhee, S. S., and Marsh, J. W. (1994). Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68, 5156-5163.
46. Robert-Guroff, M., Popovic, M., Gartner, S., Markham, P., Gallo, R. C., and Reitz, M. S. (1990). Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64, 3391-3398.
47. Saksela, K., Cheng, G., and Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14, 484-491.
48. Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C. (1994). Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 1539-1543.
49. Sawai, E. T., Baur, A. S., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C. (1995). A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270, 15307-15314.
50. Schwartz, O., Dautry-Varsat, A., Goud, B., Marechal, V., Subtil, A., Heard, J. M., and Danos, O. (1995). Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69, 528-533.
51. Schwartz, O., Marechal, V., Danos, O., and Heard, J. M. (1995). Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053-4059.
52. Shugars, D. C., Smith, M. S., Gleuck, D. H., Nantermet, P. V., Seillier-Moiseiwitsch, F., and Swanstrom, R. (1993). Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 67, 4639-4650.
53. Skowronski, J., Parks, D., and Mariani, R. (1993). Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12, 703-713.
54. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C., and Richman, D. D. (1994). The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123.
55. Trono, D. (1995). HIV accessory proteins: leading roles for the supporting cast. Cell 82, 189-192.
56. Von Schwedler, U., Song, J., Aiken, C., and Trono, D. (1993). vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945-4955.
57. Terwilliger, E. F., Sodroski, J. G., Rosen, C. A., and Haseltine, W. A. (1986). Effects of mutations within the 3′ orf-open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. J. Virol. 60, 754-760.
58. Welker, R., Kottler, H., Kalbitzer, H. R., and Krausslich, H. G. (1996). Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219, 228-236.
59. Wiskerchen, M., and Muesing, M. A. (1995a). Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. J. Virol. 69, 597-601.
60. Wiskerchen, M., and Muesing, M. A. (1995b). Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69, 376-386.